Cardioprotective effects of sevoflurane, isoflurane, and propofol in coronary surgery patients: A randomized controlled study

Heart Surgery Forum

Volumn 12, Issue 1, 2009, Pages

  Yildirim, Vedat ^a   Doganci, Suat ^a   Aydin, Ahmet ^a   Bolcal, Cengiz ^a   Demirkilic, Ufuk ^a   Cosar, Ahmet ^a  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

DIAZEPAM; FREE RADICAL; GLUTATHIONE PEROXIDASE; ISOFLURANE; MIDAZOLAM MALEATE; NERVIUM; NITRATE; NITRIC OXIDE; NITRITE; PROPOFOL; REMIFENTANIL; SEVOFLURANE; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; TROPONIN I; UNCLASSIFIED DRUG; VECURONIUM; CARDIOTONIC AGENT; ETHER DERIVATIVE; INHALATION ANESTHETIC AGENT;

ADULT; AGED; ARTERY CLAMP; ARTICLE; CARDIOPLEGIA; CARDIOPULMONARY BYPASS; CENTRAL VENOUS PRESSURE; CLINICAL TRIAL; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY SURGERY; CORONARY HEMODYNAMICS; ENZYME ACTIVITY; FEMALE; HEART ATRIUM APPENDAGE; HEART FUNCTION; HEART INDEX; HEART MUSCLE ISCHEMIA; HEART OUTPUT; HEART PROTECTION; HEART RIGHT ATRIUM; HUMAN; INTENSIVE CARE UNIT; LIPID PEROXIDATION; LUNG ARTERY PRESSURE; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; OUTCOME ASSESSMENT; OXIDATIVE STRESS; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PULMONARY ARTERY OCCLUSION PRESSURE; RANDOMIZED CONTROLLED TRIAL; REPERFUSION INJURY; STATISTICAL SIGNIFICANCE; SURGICAL PATIENT; SYSTEMIC VASCULAR RESISTANCE; TREATMENT OUTCOME; CORONARY ARTERY BYPASS GRAFT; HEART INFARCTION; HEART LEFT VENTRICLE FUNCTION; INHALATIONAL DRUG ADMINISTRATION;

ADMINISTRATION, INHALATION; AGED; ANESTHETICS, INHALATION; CARDIOTONIC AGENTS; CORONARY ARTERY BYPASS; FEMALE; HUMANS; ISOFLURANE; MALE; METHYL ETHERS; MYOCARDIAL INFARCTION; PROPOFOL; TREATMENT OUTCOME; VENTRICULAR DYSFUNCTION, LEFT;

EID: 66649129737     PISSN: 10983511     EISSN: 15226662     Source Type: Journal    
DOI: 10.1532/HSF98.20081137     Document Type: Article

References (32)

1. Allaouchiche B, Debon R, Goudable J, et al. 2001. Oxidative stress status during exposure to propofol, sevoflurane and desflurane. Anesth Analg 93:981-5.
2. Ansley DM, Sun J, Visser WA, et al. 1999. High dose propofol enhances red cell antioxidant capacity during CPB in humans. Can J Anaesth 46:641-8.
3. Aydin A, Orhan H, Sayal A, Ozata M, Sahin G, Isimer A. 2001. Oxidative stress and nitric oxide related parameters in type II diabetes mellitus: effects of glycemic control. Clin Biochem 34:65-70.
4. Baines CP, Goto M, Downey JM. 1997. Oxygen radicals released during ischemic preconditioning contribute to cardioprotection in the rabbit myocardium. J Mol Cell Cardiol 29:207-16.
5. Becker LB. 2004. New concepts in reactive oxygen species and cardiovascular reperfusion physiology. Cardiovasc Res 61:461-70.
6. Berger RL, Davis KB, Kaiser GC, et al. 1981. Preservation of the myocardium during coronary artery bypass grafting. Circulation 64:II61-6
7. Bolcal C, Yildirim V, Doganci S, et al. 2007. Protective effects of antioxidant medications on limb ischemia reperfusion injury. J Surg Res 139:274-9.
8. De Hert SG, ten Broecke PW, Mertens E, et al. 2002. Sevoflurane but not propofol preserves myocardial function in coronary surgery patients. Anesthesiology 97:42-9.
9. De Hert SG, Cromheecke S, ten Broecke PW, et al. 2003. Effects of propofol, desflurane, and sevoflurane on recovery of myocardial function after coronary surgery in elderly high-risk patients. Anesthesiology 99:314-23.
10. De Hert SG, Van der Linden PJ, Cromheecke S, et al. 2004. Cardioprotective properties of sevoflurane in patients undergoing coronary surgery with cardiopulmonary bypass are related to the modalities of its administration. Anesthesiology 101:299-310.
11. De Hert SG, Van der Linden PJ, Cromheecke S, et al. 2004. Choice of primary anesthetic regimen can influence intensive care unit length of stay after coronary surgery with cardiopulmonary bypass. Anesthesiology 101:9-20.
12. De Ruijter W, Musters RJ, Boer C, et al. 2003. The cardioprotective effect of sevoflurane depends on protein kinase C activation, opening of mitochondrial K(+)(ATP) channels, and the production of reactive oxygen species. Anesth Analg 97:1370-6.
13. Ding HL, Zhu HF, Dong JW, et al. 2005. Inducible nitric oxide synthase contributes to intermittent hypoxia against ischemia/reperfusion injury. Acta Pharmacol Sin 26:315-22.
14. Etievent JP, Chocron S, Toubin G, et al. 1995. Use of cardiac troponin I as a marker of perioperative myocardial ischemia. Ann Thorac Surg May 59:1192-4.
15. Guarracino F, Landoni G, Tritapepe L, et al. 2006. Myocardial damage prevented by volatile anesthetics: a multicenter randomized controlled study. J Cardiothorac Vasc Anesth 20:477-83.
16. Hanouz JL, Yvon A, Massetti M, et al. 2002. Mechanisms of desflurane-induced preconditioning in isolated human right atria in vitro. Anesthesiology 97:33-41.
17. Jacquet L, Noirhomme P, El Khoury G, et al. 1998. Cardiac troponin I as an early marker of myocardial damage after coronary bypass surgery. Eur J Cardiothorac Surg 13:378-84.
18. Jakobsen CJ, Berg H, Hindsholm KB, Faddy N, Sloth E. 2007. The influence of propofol versus sevoflurane anesthesia on outcome in 10,535 cardiac surgical procedures. J Cardiothorac Vasc Anesth 21:664-71.
19. Kersten JR, Schmeling TJ, Hettrick DA, Pagel PS, Gross GJ, Warltier DC. 1996. Mechanism of myocardial protection by isoflurane. Role of adenosine triphosphate-regulated potassium (KATP) channels. Anesthesiology 85:794-807.
20. Kevin LG. 2003. Propofol and myocardial lipid peroxidation. Br J Anaesth 253:253-4.
21. Kokita N, Hara A. 1996. Propofol attenuates hydrogen peroxide-induced mechanical and metabolic derangements in the isolated rat heart. Anesthesiology 84:117-27.
22. Landoni G, Biondi-Zoccai GGL, Zangrillo A, et al. 2007. Desflurane and sevoflurane in cardiac surgery: a meta-analysis of randomised clinical trials. J Cardiothorac Vasc Anesth 21:502-11.
23. Lefevre G, Beljean-Leymarie M, et al. 1998. Evaluation of lipid peroxidation by measuring thiobarbituric acid reactive substances Ann Biol Ann Biol Clin (Paris) 56:305-19.
24. Mangano DT. 1985. Biventricular function after myocardial revascularization in humans: deterioration and recovery patterns during the first 24 hours. Anesthesiology 62:571-7.
25. Mullenheim J, Ebel D, Frabetadorf J, et al. 2002. Isoflurane preconditions myocardium against infarction via release of free radicals. Anesthesiology 96:934-40.
26. Murphy PG, Myers DS, Davies MJ, et al. 1992. The antioxidant potential of propofol (2,6-diisopropylphenol). Br J Anaesth 68:613-8.
27. Sadony V, Korber M, Albes G, et al. 1998. Cardiac troponin I plasma levels for diagnosis and quantitation of perioperative myocardial damage in patients undergoing coronary artery bypass surgery. Eur J Cardiothorac Surg 13:57-65.
28. Sayin MM, Ozatamer O, Tasoz R, et al. 2002. Propofol attenuates myocardial lipid peroxidation during coronary artery bypass grafting surgery. Br J Anaesth 89: 242-6.
29. Sommerschild HT, Kirkeboen KA. 2002. Preconditioning-endogenous defence mechanisms of the heart. Acta Anaesthesiol Scand 46:123-37.
30. Tritapepe L, Landoni G, Guarracino F, et al. 2007. Cardiac protection by volatile anaesthetics: a multicentre randomized controlled study in patients undergoing coronary artery bypass grafting with cardiopulmonary bypass. Eur J Anaesthesiol 24:323-31.
31. Ytrehus K, Hegstad AC. 1991. Lipid peroxidation and membrane damage of the heart. Acta Physiol Scand Suppl 599:81-91.
32. Zaugg M, Lucchinetti E, Spahn DR, Pasch T, Garcia C, Schaub MC. 2002. Differential effects of anesthetics on mitochondrial K(ATP) channel activity and cardiomyocyte protection. Anesthesiology 97:15-23.